JPRN-UMIN000018334
Completed
未知
Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus. - Efficacy of trelagliptin for glucose fluctuation, oxidative stress and inflammation in patients with type 2 diabetes mellitus.
Ise Red Cross Hospital Department of Metabolic Diseases0 sites20 target enrollmentJuly 17, 2015
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Ise Red Cross Hospital Department of Metabolic Diseases
- Enrollment
- 20
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •1\) Type 1 diabetes 2\) Had ketosis or coma within 6 month 3\) Secondary diabetes 4\) Patients receiving insulin or GLP\-1 analogue therapy 5\) Poor\-controlled diabetes (HbA1c\>10\.0 % or fasting blood glucose levels\>250mg/dl) 6\) History of stroke, acute coronary syndrome or any cardiovascular diseases needed for inpatient\-treatments within 6 months 7\) Either level of aspartate aminotransaminase or alanine aminotransferase exceed three\-fold of the normal limits 8\) Renal insufficiency: serum creatinine\>1\.5 or Ccr\<50ml/min 9\) Malignancies or other diseases with poor prognosis 10\) Pregnant 11\) Subjects whose doctor in charge do not agree to join the trial
Outcomes
Primary Outcomes
Not specified
Similar Trials
Unknown
Phase 4
The Effect of Saxagliptin on Glucose Fluctuation and Immune Regulation in Patients With Type 1 DiabetesType 1 DiabetesNCT02307695Nanjing Medical University184
Completed
Not Applicable
Efficacy of ipragliflozin on glucose metabolismtype 2 diabetes mellitusJPRN-UMIN000013921Shiraiwa Medical Clinic10
Completed
Not Applicable
Effects of sitagliptin on daily glucose fluctuation in Japanese type 2 diabetic outpatients inadequately controlled with insulin therapyJPRN-UMIN000012735Aichi Medical University Division of Diabetes, Department of Internal Medicine, Diabetes Center30
Completed
Not Applicable
Effects of teneligliptin on glycemic control and bone metabolic markers in diabetic patients undergoing hemodialysisdiabetic patients undergoing hemodialysisJPRN-UMIN000010780Diamond study group10
Completed
Phase 4
The efficacy of teneligliptin in diabetic patients on hemodialysisType2 diabetic patients on hemodialysisJPRN-UMIN000010999Kawashima Hospital30